Julián A, Jiménez A A, de Górgolas M, Fernández R, Fernández M L
División de Enfermedades Infecciosas. Fundación Jiménez Díaz. Universidad Autónoma de Madrid, Spain.
Enferm Infecc Microbiol Clin. 2001 Aug-Sep;19(7):297-303. doi: 10.1016/s0213-005x(01)72649-3.
Thirty-one cases of human listeriosis seen from 1971-1999 were reviewed. cases were grouped as follows: Group I composed of 14 patients were studied in the period 1971-1984; and group II composed of 17 cases studied in the period 1985-1999. We tried to assess changes in the incidence, clinical findings and outcome in both periods. The incidence of listeriosis remained constant along the years, 1.2 cases/20,000 discharges. The mean age of the patients significantly increased along the years (55 11 years versus 68 12 years; p 0.002). 77% of cases had one or more underlying diseases predisposing to listeriosis. We observed an increasing number of listeriosis in patients without chronic diseases in recent years. Listeriosis presented as meningitis or primary sepsis. Mortality was 61% and was strictly associated with the severity of the underlying disease. Patients with meningoencephalitis and seizures had a worse prognosis. We did not observe differences in mortality of patients who were treated with beta-lactam monotherapy in comparison with those who were treated with beta-lactam/aminoglucoside combination. Cotrimoxazole was uniformly successful treatment of human listeriosis in this series.
回顾了1971年至1999年间确诊的31例人类李斯特菌病病例。病例分组如下:第一组由1971年至1984年期间研究的14例患者组成;第二组由1985年至1999年期间研究的17例病例组成。我们试图评估这两个时期发病率、临床表现和预后的变化。李斯特菌病的发病率多年来保持稳定,为1.2例/20000例出院病例。患者的平均年龄多年来显著增加(55±11岁对68±12岁;p<0.002)。77%的病例有一种或多种易患李斯特菌病的基础疾病。近年来,我们观察到无慢性疾病患者中李斯特菌病病例数有所增加。李斯特菌病表现为脑膜炎或原发性败血症。死亡率为61%,且与基础疾病的严重程度密切相关。患有脑膜脑炎和癫痫的患者预后较差。与接受β-内酰胺/氨基糖苷类联合治疗的患者相比,我们未观察到接受β-内酰胺单药治疗的患者在死亡率上存在差异。在本系列中,复方新诺明是治疗人类李斯特菌病的统一成功疗法。